Provided by Tiger Trade Technology Pte. Ltd.

Zoetis

115.67
-0.3200-0.28%
Post-market: 116.000.3300+0.29%19:43 EDT
Volume:11.42M
Turnover:1.32B
Market Cap:48.83B
PE:19.21
High:117.19
Open:115.95
Low:114.36
Close:115.99
52wk High:172.23
52wk Low:114.36
Shares:422.13M
Float Shares:422.00M
Volume Ratio:2.59
T/O Rate:2.71%
Dividend:2.03
Dividend Rate:1.75%
EPS(TTM):6.02
EPS(LYR):6.02
ROE:65.99%
ROA:15.25%
PB:14.66
PE(LYR):19.21

Loading ...

Zoetis Receives European Commission Marketing Authorization for Portela® (Relfovetmab) to Alleviate Pain Associated With Osteoarthritis in Cats

THOMSON REUTERS
·
Oct 29, 2025

Zoetis Inc - Anticipates Portela Availability in EU in 2026

THOMSON REUTERS
·
Oct 29, 2025

BRIEF-Zoetis Appoints Stephanie Tilenius To Its Board Of Directors

Reuters
·
Oct 28, 2025

Zoetis Appoints Stephanie Tilenius to Board of Directors

Reuters
·
Oct 28, 2025

Zoetis Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Oct 28, 2025

Is Zoetis Worth Watching After a 22% Slide in the Past Year?

Simply Wall St.
·
Oct 22, 2025

Zoetis Stock: Outlook Remains Muted

Benzinga_recent_news
·
Oct 21, 2025

2 Large-Cap Stocks with Exciting Potential and 1 We Avoid

stock_story_highlight
·
Oct 21, 2025

Zoetis Is Maintained at Neutral by UBS

Dow Jones
·
Oct 21, 2025

Zoetis price target lowered to $158 from $165 at UBS

TIPRANKS
·
Oct 20, 2025

UBS Cuts Zoetis Price Target to $158 From $165, Maintains Neutral Rating

MT Newswires Live
·
Oct 20, 2025

UBS Remains a Hold on Zoetis (ZTS)

TIPRANKS
·
Oct 20, 2025

Zoetis Inc : UBS Cuts Target Price to $158 From $165

THOMSON REUTERS
·
Oct 20, 2025

How Investors Are Reacting To Zoetis (ZTS) Winning Canadian Approval for Lenivia Osteoarthritis Therapy

Simply Wall St.
·
Oct 16, 2025

Zoetis Receives Health Canada Approval for Lenivia®, First Long-Acting Monoclonal Antibody Therapy for Osteoarthritis Pain in Dogs

Reuters
·
Oct 15, 2025

Zoetis Announces Health Canada Approval of Lenivia® (Izenivetmab Injection) for Alleviation of Osteoarthritis (Oa) Pain in Dogs

THOMSON REUTERS
·
Oct 15, 2025

Buy Rating on Zoetis: Strategic Initiatives and Long-term Growth Potential Amid Short-term Challenges

TIPRANKS
·
Oct 14, 2025

Leerink Partners Adjusts Zoetis' Price Target to $152 From $153, Keeps Market Perform Rating

MT Newswires Live
·
Oct 13, 2025

Zoetis (ZTS): Exploring Valuation as Decade-Long Dividend Growth Signals Financial Strength

Simply Wall St.
·
Oct 11, 2025

Zoetis Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Oct 11, 2025